Podcasts about guest editor

Britney Spears is one of the biggest music stories in the world right now, but it's not because of her music.It's to do with the saga of her controversial 13 year long conservatorship.In 2019 the Free Britney hashtag and movement went viral. More recently we've seen a series of documentaries covering the issue, and the story has grown and grown.Then, a few weeks ago, after years of silence, we saw Britney finally speak out publicly. She confirmed years worth of speculation regarding her conservatorship, and perhaps most importantly, the role her father Jamie Spears has played in all of it.So could the 13 year battle to free Britney finally be coming to an end?Guest: Editor of Music Junkee, Jules LeFevre See acast.com/privacy for privacy and opt-out information.

Guest Editor and author Marco Garrido discusses his special issue "Global South" and his article, "Reconceptualizing Segregation in the Global South," published in the March 2021 issue of City & Community.

Growing concern about far-right extremists in Australia has led to the creation of a new federal inquiry, but the inquiry has revealed that one police force is out of step with our national security agencies. Today, Osman Faruqi on the emboldened far-right in Australia, and whether enough is being done to counter them.Guest: Editor of 7am, Osman Faruqi.Background reading: Victoria Police and extremism in The Saturday Paper See acast.com/privacy for privacy and opt-out information.

Over the years Kit Kemp MBE has been forging an internationally-acclaimed reputation, not only for her unique hotel interiors as Founder and Creative Director of Firmdale Hotels but also as a successful textiles, fragrance and homewares designer, author and a highly-respected champion of British art, craft and sculpture. With a collection of ten couture hotels in London and New York, Kit is celebrated for her individual and original approach to the way she transforms and arranges buildings, with a colourful and detailed storytelling in her design. She has won many awards for her designs including House & Garden’s Hotel Designer of the Year, The Crown Estate’s Urban Business Award, CN Traveller’s Best Hotel in the World for Design and Andrew Martin International Interior Designer of the Year. Kit has collaborated with leading global design brands such as Wedgwood, Wilton Carpets, Andrew Martin, Anthropologie, Christopher Farr, Chelsea Textiles, C P Hart, Porta Romana and Fine Cell Work, creating collections including tableware, fragrance, furniture, fabrics and wallpaper. In 2012, Kit published her first book, A Living Space which follows an inspiring personal voyage through the many spaces she has designed. This was followed by a second book, Every Room Tells A Story and her third and latest book, Design Thread.  Kit Kemp has been invited as Guest Editor for Homes & Gardens and Hospitality Design USA. In 2017 Shop Kit Kemp was launched. An online store complete with a range of products ready to buy for the home created by Kit Kemp and her design team. Spring 2019 saw Kit Kemp launch an exclusive collaboration with New York department store, Bergdorf Goodman. The Loft on the seventh floor was transformed into The World of Kit Kemp where her collections of furniture, fabrics, fragrance and home accessories were brought together for the first time. In 2019, Kit Kemp launched a blog called Kit Kemp’s Design Thread. This new website showcases her world of colour and design including collaborations, films and an insight into her work and day-to-day experiences in her Design Studio Kit Kemp is a Trustee of Fine Cell Work and the Heritage of London Trust.

Professor Calvin Moorley RN, PhD is a Professor in Nursing Research and Diversity in Care, Adult Nursing Department at London South Bank University, with a background in public health and diversity in care. His research focuses on the interplay of gender, culture ethnicity and health. Since graduating from the University of Essex as an adult registered nurse, Calvin has followed a clinical/academic career, remaining close to clinical nursing, particularly in the critical care environment, and currently works one shift a week in an inner-city hospital in central London. He supports clinical nursing at the point-of-care through his role as a link lecturer for Barts Health NHS Trust. Calvin has a keen interest in how health is theorized using social media platforms. He has published widely in nursing and social media and is developing an area on the use of social media to enhance research literacy of nurses. His most recent works include Knowledge, attitude and beliefs on sex among Black Africans; Psychosexual Experiences of FGM survivors and Experience of Stroke among Caribbean populations in the UK. Calvin is well recognised in the field and this can be seen in his esteem factors which include: Guest Editor for a special issue of Journal of Clinical Nursing on LGBTI Health 2017; the Mary Seacole Prize for Leadership in Nursing 2013/14 by the Royal College of Nursing, and various editorships including Evidence Based Nursing Journal and Journal of Transcultural Nursing. Calvin collaborates nationally and internationally including working with teams in Trinidad, Jamaica and Australia. He publishes widely in various nursing journals, and has a current H-index of 6 (Google Scholar 2019). Calvin further serves the nursing community on various panels such as the Nursing Times Student Nurses awards; Edith Cavell Awards and Health Service Journal awards. A key objective of Calvin's programme of work is to reduce the gap in health inequalities through developing and improving cultural competence and health literacy. Support this podcast

After more than 100 days of strict lockdown, Victorians finally have a new path out of restrictions. It signals a more gradual easing than the government originally hoped, after outbreaks amongst frontline workers led to a spike in case numbers Today, Osman Faruqi on the story behind the slower path out of lockdown and where the risk now lies. Guest: Editor of 7am Osman Faruqi.Background reading: Where Victoria’s second-wave cases are still occurring in The Saturday Paper See acast.com/privacy for privacy and opt-out information.

Victoria’s second wave has been attributed to an outbreak of Covid-19 amongst private contractors working in hotel quarantine, and now government documents reveal more contractors at quarantine hotels have tested positive for the virus. Today, Osman Faruqi on Melbourne’s ‘hot hotels’ and the risks they might still pose. Guest: Editor of 7am, Osman Faruqi. See acast.com/privacy for privacy and opt-out information.

Confidential documents leaked to The Saturday Paper show that hospitals remain a key area of coronavirus transmission, while doctors and nurses in Melbourne complain that they’re still not getting access to proper protective equipment. Today, Osman Faruqi on how healthcare worker infections are contributing to the length of Victoria’s second wave.Guest: Editor of 7am Osman Faruqi.Background reading: Confidential document reveals healthcare outbreaks in The Saturday Paper See acast.com/privacy for privacy and opt-out information.

Could AI have predicted the pandemic? How is it helping the health care system? Recent 'Test and Trace' programmes have raised growing concerns over data protection and privacy in the wake of the global pandemic. Find out how AI helping us navigate the gradual return to normal life and explore with us how the pandemic has changed how we should use AI in the future. Join writer, broadcaster and UCL alumna, Vivienne Parry, as we return this week with Prof Kate Jones (Chair of Ecology & Biodiversity, Division of Biosciences), Dr Michael Veale (Lecturer in Digital Rights and Regulation, Laws) and Dr Ali Parsa (Alumnus & CEO of Babylon). Special thanks to our Guest Editor, Prof Geraint Rees, Dean of the Faculty of Life Sciences. If you would like to take part in a future episode, or if you’ve got a question about the pandemic you’d like UCL researchers to answer, please get in touch by emailing UCL’s Communications and Marketing team on minds@ucl.ac.uk – we’d love to hear from you. More info: https://www.ucl.ac.uk/ucl-minds/coronavirus Transcript: https://www.ucl.ac.uk/ucl-minds/podcasts/coronavirus/transcript-episode-18

This is a story about Australia’s psyche and the way our connection to policing makes us unique. During this pandemic, police have been handed unprecedented new powers, in stark contrast to the response elsewhere in the word. Today, Osman Faruqi on the nexus between police, politicians and the media. Guest: Editor of 7am, Osman Faruqi.Background reading: Policing as part of the national psyche in The Saturday Paper See acast.com/privacy for privacy and opt-out information.

During this 4th of July 2020 timeframe, Episode 3 takes the Declaration of Independence preamble and relates this historic document and its preambles iconic words to the values represented by leaders today.  The focus of this episode is on disruption, disruption to our health care system, our economic system and the current spotlight being placed on longstanding racial discrimination and inequality.Sources include:Christensen, Clayton M. (1997). The innovator’s dilemma: when new technologies cause great firms to fail. Boston, Massachusetts, USA: Harvard Business School Press. Dillon, Karen, Guest Editor, MIT Sloan Management Review (Spring 2020, Volume 61, Number 3), What will it take to innovate and compete over the next decade? Cambridge, Massachusetts, USA: MIT Sloan Management Review. Poo, Al-jen and Shah, Palak, The Future of Work Isn’t What People Think it is, May 7, 2020. New York, New York, The New York Times.

As the Black Lives Matter movement reignites calls for action on Indigenous disadvantage and incarceration, politicians and the media in Australia have turned it into a culture war that deliberately ignores the goals of protestors. Guest: Editor of 7am Osman Faruqi.Background reading:Deflecting from the real issues of Black Lives Matter in The Saturday PaperThe Saturday PaperThe MonthlyFor more information on today’s episode, visit 7ampodcast.com.au. See acast.com/privacy for privacy and opt-out information.

Bringing science, history & culture together can be so rewarding for learners! In this episode, we chat with Allyson Mitchell who is the Outreach Programs Manager for Penn Museum, also known as the University of Pennsylvania Museum of Archaeology and Anthropology. From interactive virtual learning to science & cultural engagement programs onsite and beyond, there's a lot happening near the heart of Philadelphia. Hosted by Ben Newsome from Fizzics Education About Allyson Mitchell Throughout her professional and scholastic careers, Allyson Mitchell has focused on how technology can act as a bridge to connect formal and informal educational spaces and programs. Prior to joining the Penn Museum, Mitchell served as the Curator of Education at the Delaware History Museum, where she created a new Distance Learning studio and supporting programs.  During her time in Delaware, Allyson acted as the State Coordinator for the National History Day program for two consecutive years. Mitchell has held a variety of positions within the Education Department at the Philadelphia Museum of Art, where she primarily worked to assist K-12 educators in integrating museum collections and technology into their classroom curriculum.  She graduated with high honours from Tyler School of Art at Temple University with a Bachelor's degree in Art History and minor Italian. She earned a Master's degree in Museum Education at the University of the Arts and recently received her certification in Global Education Leadership. Mitchell has presented at the 2016 Mid-Atlantic Association of Museum Conference and the 2017 American Association of Museum Expo and Conference to discuss the implications of distance learning in a museum setting. In Summer 2019, Mitchell served as Guest Editor for the Journal of Museum Education, 44:3- Virtual Visits: Museums Beaming in Live to which she also contributed an article focusing on her work at the Penn Museum. Penn Museum Website: www.penn.museum Programs: Interactive Virtual Learning Programs Page for families, educational groups, and adults. Quick links to digital resources: Great Lecture Playlists, Digital Daily Digs, At-Home Anthropology for Kids Artifact Lab Blog: https://www.penn.museum/sites/artifactlab/ Center For The Analysis of Archaeological  Materials (CAAM) https://www.penn.museum/learn/penn-students/caam Virtual Learning Journal of Museum Education, 44.3 – ‘Virtual Visits: Museums Beaming in Live!' link to full issue *Be in touch with mallysonconsult@gmail.com for information about specific articles Links to Authors Institutions EarthEco International – Click here to learn more about their view into science through Interactive Virtual Learning workshops! Cleveland Museum of Art –Discover more about looking at objects as artists with a LIVE virtual visit by clicking here Find out more about these and more Content Providers at the Center for Interactive Learning and Collaboration Philadelphia Science Festival https://www.fi.edu/psf About the FizzicsEd Podcast Hosted by Ben Newsome from Fizzics Education With interviews with leading science educators and STEM thought leaders, this science education podcast is about highlighting different ways of teaching kids within and beyond the classroom. It's not just about educational practice & pedagogy, it's about inspiring new ideas & challenging conventions of how students can learn about their world! https://www.fizzicseducation.com.au/ Know an educator who'd love this STEM podcast episode?  Share it! The FizzicsEd podcast is a member of the Australian Educators Online Network (AEON ) http://www.aeon.net.au/ See omnystudio.com/listener for privacy information.

In this episode of the IJGC podcast, Dr. Michael Frumovitz, a Guest Editor on the March 2020 special issue on Advances in Lymphatic Mapping and Sentinel Lymph Node Biopsy in Gynecologic Cancers, is joined by Dr. Al Covens to discuss management of isolated tumor cells in sentinel nodes in women with cervical cancer. Dr. Coven's article, "Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?" is the Lead article for the issue (https://ijgc.bmj.com/content/early/2019/12/20/ijgc-2019-000928). Dr. Covens is the chair of Gyn Oncology at the University of Toronto, and the Head of Gyn Oncology at Sunnybrook Health Sciences Centre.

Listen to the Episode Alexandra Fuller Interview Synopsis Today’s episode brings us to a highway in the Midwest, USA, where Alexandra Fuller speaks with us about challenging dominant narratives and about her experience as Guest Editor for the Best American Travel Writing 2019.  Alexandra Fuller is an award-winning writer whose books include Don’t Let’s Go to the Dogs Tonight (2001), Cocktail Hour Under The Tree of Forgetfulness (2011), Scribbling the Cat: Travels with an African Soldier (2014), and Travel Light, Move Fast (2019). She’s written for publications like The New Yorker, National Geographic, and Granta to name a few. In the interview, we also discuss the Des Moines Arts Center's exhibit on Monument Valley and Bertolt Brecht's A War Primer.  More Episodes & Support I hope you enjoyed this episode of the Travel Writing World podcast! Please consider supporting the show with a few dollars a month, less than a cup of coffee, to help keep our show alive and advertisement-free. You can also support the show by leaving a positive review on Apple Podcasts or in your favorite podcasting app, subscribing to the show, and following us on Twitter & Instagram. Finally, join the Travel Writing World newsletter to receive your free copy of The Travel Writer’s Guidebook. You will also receive monthly dispatches & reports with podcast interviews, travel writing resources, & book recommendations. Thanks for your support! Intro Music Peach by Daantai (Daantai’s Instagram) .ugb-e87b087 .ugb-block-content{justify-content:center}.ugb-e87b087 .ugb-button1{background-color:#0693e3;border-radius:4px !important}.ugb-e87b087 .ugb-button1 .ugb-button--inner,.ugb-e87b087 .ugb-button1 svg{color:#ffffff}.ugb-e87b087 .ugb-button1:before{border-radius:4px !important}.ugb-e87b087 .ugb-inner-block{text-align:center}SUBSCRIBE TO THE PODCAST

Guest Editor, Larry Forney, discusses articles from the January 2020 BJOG themed issue ‘The Microbiome and Women’s Health’. The original Editorial is available at: https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.16010

Each year, The Monthly assembles a panel of critics and artists to nominate 10 standout pieces of Australian culture from the past 12 months. These works are named as the winners of The Monthly Awards. We spoke to the magazine’s editor, Nick Feik, and critic Alison Croggon, who was one of the judges.Guest: Editor of The Monthly Nick Feik and critic Alison Croggon.Background reading:The Monthly Awards 2019 in The MonthlyThe MonthlyThe Saturday PaperFor more information on today’s episode, visit 7ampodcast.com.au. See acast.com/privacy for privacy and opt-out information.

In this episode of the Latin American Perspectives podcast, Alexander Scott, Outreach Coordinator for Latin American Perspectives, Inc., discusses the September 2019 issue, "Politics, Society, and Culture in Postconflict Peru" with Guest Editor (and LAP Film and Media Co-Editor) Kristi M. Wilson.

This episode's guest is Jack Easley, DVM, MS, DABVP, DAVDC (Eq), owner of Easley Equine Dentistry based in Shelbyville, Kentucky.Easley is an active member of the American Association of Equine Practitioners. He is a member of the American Veterinary Dental Society, International College of Equine Veterinary Odontologists, American Veterinary Medical Association, Kentucky Veterinary Medical Association, Kentucky Association of Equine Practitioners, Kentucky Veterinary Medical Association, and Equine Dental Vets (an Australian organization with world-wide educational opportunities.For more than 30 years, Easley has globally promoted, lectured, and written about equine veterinary dentistry. Easley was the co-editor and a major contributor to Equine Dentistry, published in 1999 by Harcourt-Brace Publishing (Saunders) and printed in Spanish and German in 2002, and he has participated in more recent editions. The Veterinary Clinics of North America released an “Advanced Equine Dentistry” edition in the Fall of 2013 with Dr. Easley serving as Guest Editor and contributor.Easley strived for more than 20 years to create a specialty board for equine dentistry, and in 2013, Easley and 18 colleagues from around the world passed the first boards given to 24 veterinarians. He received Diplomate status in the spring of 2014, when the American Veterinary Dental College Equine Specialty was formally recognized by the American College of Veterinary Dentistry and the AVMA.This episode of Disease Du Jour focuses on Equine Dentistry. We talk about how much has changed in equine dentistry, the wide variety of dental diseases horses can have, the need for a good dental exam with the right tools, the use of radiographs, and what horse owners expect today in equine dental care. See acast.com/privacy for privacy and opt-out information.

This is the seventh episode of Listen to the Editors, a series of interviews with journal editors to unveil the trends in research for Operations and Supply Chain Management. In this episode we are interviewing the editors-in-chief for the Journal of Business Logistics (JBL), professors Thomas Goldsby and Walter Zinn. * JBL has 150,000 downloads in 2018. * Global spread of downloads: US: 18%, UK: 12%, DE,CN: 7% – 1/3 from outside the top 10 countries. - 3 open calls for special issues: * Talent Management in SCM - due Aug. 31 * Artificial Inteligence, Robotics, and Employment - due Oct. 31 * Digital Supply Chain - Dec. 1 Initiatives the Journal of Business Logistics is undertaking to publicize the papers and increasing their impact? * Some papers are reformatted and published in the Supply Chain Quarterly * Edge Conference - 3,000 supply chain managers * Part of doctoral consortium is have the PhD candidates walk in the conference, listen to the managers, and report back their findings. The host for this show is Iuri Gavronski, Associate Professor for the Graduate Program in Business for the UNISINOS Jesuit University. Listen to the editors is an initiative of the Operations and Supply Chain Management division of the Academy of Management. We post our interviews monthly in our division website. You can discuss any of the topics of this episode using our interactive tool, https://connect.aom.org. Using the discussion section of our site, you can also post suggestions for questions, journal editors you would like to hear from, and requests for clarifications. You can also subscribe to our podcast in Apple Podcasts, Spotify, or with the Podcast Addict app on Android. Websites for the Journal: ========================= Wiley’s main page for JBL (where the open CfPs can be found): https://onlinelibrary.wiley.com/journal/21581592 Also, several papers can be freely accessed there, including Walter’s “Historical Review of Postponement Research.” Other info: =========== The 40th Anniversary issue can be found at: https://onlinelibrary.wiley.com/toc/21581592/2019/40/1. CSCMP’s Supply Chain Quarterly can be found at: https://www.supplychainquarterly.com/ Cites to some referenced papers in the podcast include: Castillo, Vincent E., John E. Bell, William J. Rose, and Alexandre M. Rodrigues. "Crowdsourcing last mile delivery: strategic implications and future research directions." Journal of Business Logistics 39, no. 1 (2018): 7-25. Garver, Michael S. "Threats to the Validity of Logistics and Supply Chain Management Research." Journal of Business Logistics 40, no. 1 (2019): 30-43. Miller, Jason W., Susan L. Golicic, and Brian S. Fugate. "Developing and testing a dynamic theory of motor carrier safety." Journal of Business Logistics 38, no. 2 (2017): 96-114 Miller, Jason W., Yemisi Bolumole, and Matthew A. Schwieterman. "Electronic Logging Device Compliance of Small and Medium Size Motor Carriers Prior to the December 18, 2017, Mandate." Journal of Business Logistics (2019). Editors' Bios: ============== Dr. Thomas Goldsby is the Harry T. Mangurian, Jr. Foundation Professor in Business, Professor of Logistics, and Chair of the Department of Marketing & Logistics at Ohio State's Fisher College of Business. Dr. Goldsby is Co-Editor-in-Chief of the Journal of Business Logistics. His research interests include logistics strategy, supply chain integration, and the theory and practice of lean and agile supply chain strategies. He has published more than 50 articles in academic and professional journals and serves as a frequent speaker at academic conferences, executive education seminars, and professional meetings. He is co-author of five books on supply chain management and logistics. Walter Zinn is Professor of Logistics. He currently serves Ohio State’s Fisher College of Business as Associate Dean for Graduate Students and Programs. He previously served as Chairman of the Department of Marketing and Logistics (2010-2016) and as Director of the Master in Business Logistics Engineering (MBLE), an innovative joint program between the Schools of Business and Engineering (2005-2010). Dr. Zinn is Co-Editor-In-Chief of the Journal of Business Logistics. He formerly served the journal as the Systems Section Editor (1997-2001) and as Guest Editor for a Special Section on Logistics, Marketing and Supply Chain Strategies in 2000. Dr. Zinn’s research interests focus primarily on the relationship between customer service policy and inventory investment; particularly consumer response to stockouts, supply chain risk management, and the effects of inventory centralization and sales forecasting on safety stocks. He is also interested in logistics issues in Latin America. At Ohio State, Professor Zinn teaches logistics courses for undergraduate, MBA and MBLE students, including Field Problems in Logistics, where graduate students conduct consulting projects for corporations. Dr. Zinn also lectured in more than 100 executive development programs and spoke in logistics conferences and meetings in the U.S. and internationally. Dr. Zinn is fluent in Spanish and in Portuguese. cknowledgements: ================= I would like to thank my research assistant, Luiz Paulo R.C. Barcellos, for his help in editing the interview. All the glitches in the recording and in the final version of the audio file, though, are my responsibility. Background music: ================= “Night & Day” by Dee Yan-Key is licensed under CC-BY-NC-SA http://freemusicarchive.org/music/Dee_Yan-Key/years_and_years_ago/08--Dee_Yan-Key-Night___Day 2019-07-31 - Episode 007

The Boys welcome Editor and Creative Director Kurt Osenlund, Guest Editor of Playboy and former Editor of Out Magazine. They talk Samantha and her new female flame, Miranda's hot make outs with chocolate, and a WILD underground sex party Kurt covered for work. Be sure to rate The Bradshaw Boys 5 stars on iTunes and we'll know you actually mean 5 Cosmos. Instagram: @TheBradshawBoys Twitter: @TheBradshawBoys Call us and leave a message: 917 410 1428 or record a voice note and email us - thebradshawboysnyc@gmail.com S4 E4 -Carrie continues to date Ray, but finds he has an ADHD problem. Miranda substitutes chocolate for sex. Charlotte deals with Trey getting a little too overconfident in bed. Samantha tells the girls she is in a relationship with Maria and is now a lesbian. Starring: Cory Cavin (@corycavin) Jon Sieber (@jonsieber) Kevin James Doyle (@kevinjamesdoyle) Guest: Kurt Osenlund (@RKurtOsenlund) Voiceover by: Katie Sieber (@katiejeanne18)   Steve Talk Theme by: Ess See (@ess_see_nyc)   Produced by: Jeremy Balon (@remybalon) at Seltzer Kings Studios (@seltzerkings) Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr Carolyn Lam:                Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr Carolyn Lam, Associate Editor from the National Heart Center and Duke National University of Singapore. Dr Greg Hundley:             And I'm Greg Hundley, also Associate Editor from the Pauley Heart Center at VCU Health in Richmond, Virginia. Dr Carolyn Lam:                I'm so excited about our feature discussion today, Greg, because it is about a familiar but very important problem of hypertension, and we will be looking at trial results of a new drug, a first in its class type of drug. And tackling a problem that is particularly important perhaps in black patients with hypertension. Well, more very soon. First, let's discuss some papers, shall we? Do you have one? Dr Greg Hundley:             My paper is from Joseph Burgoyne from King's College in London and pertains to resveratrol. Now, resveratrol is a non-flavonoid polyphenolic compound that has been found in the skin of several fruits, with the most notable being grapes. The compound exhibits beneficial effects, including the prevention of cardiovascular neurologic diseases, cancer, metabolic syndrome, as well as it promotes bone and eye health. And in this study, the investigative team explains how resveratrol may mediate its numerous beneficial effects including lowering of blood pressure by direct thiol oxidation. Also, they demonstrate that resveratrol can counter-intuitively induce direct protein oxidation, a process that is enhanced under pro-oxidative conditions associated with disease. The oxidation of cyclic GMP dependent protein kinase 1 alpha, or PKG1 alpha, by resveratrol lowers blood pressure in hypertensive mice. Dr Carolyn Lam:                Okay. But what does that mean for us clinically, Greg? Dr Greg Hundley:             Well, the results demonstrate how blood pressure can be lowered by using resveratrol, and targeting cysteine 42, or PKG1 alpha, may provide a new class of anti-hypertensive agents. In addition, identifying additional proteins modified by resveratrol may provide new targets for therapy to treat cardiovascular disease. Carolyn, how about your first paper? Dr Carolyn Lam:                We are going to look at the further results of the ODYSSEY OUTCOMES trial. And as a reminder, ODYSSEY OUTCOMES was a double-blind randomized comparison of the PCSK9 antibody Alirocumab with placebo in almost 19,000 patients who had an acute coronary syndrome 1-12 months previously and elevated at the atherogenic lipoproteins despite intensive statin therapy.                                                 And that trial found that Alirocumab reduced the risk of the primary composite outcome of coronary heart disease, death, ischemic stroke, myocardial infarction, or unstable angina requiring hospital admissions. The current paper looked further at the effects of Alirocumab on death. Dr Greg Hundley:             So Carolyn, what did they find? Dr Carolyn Lam:                Well, there are quite a number of findings here. The first, there were fewer deaths in total that occurred with the PCSK9 inhibitor Alirocumab versus placebo, and this resulted from a non-significantly cardiovascular and non-cardiovascular deaths with Alirocumab. The second finding was that in a pre-specified analysis of more than 8,200 patients eligible for 3 or more years of follow-up, Alirocumab reduced death.                                                 And then, the third finding was that patients with non-fatal cardiovascular events were at increased risk for both cardiovascular and non-cardiovascular deaths, and a post-Hoc analysis found that compared to patients with a lower LDL, those with a baseline LDL above 100 had a greater absolute risk of death, and a larger mortality benefit with Alirocumab. In the Alirocumab group, all cause death declined with a lower achieved LDL achieved at 4 months of treatment to a level of approximately 30.                                                 So in summary, Alirocumab added to intensive statin therapy, has the potential to reduce death after acute coronary syndrome, particularly if treatment is maintained for 3 or more years, and if baseline LDL is 100 or more, or if achieved LDL is low. Dr Greg Hundley:             That's great, Carolyn. My next paper is going to talk a little bit about endothelial cells. And what I think we're going to learn is that not all endothelial cells are alike. This comes from Dr Rajat Gupta from Brigham and Women's Hospital, and I really thought this was an interesting article that used single-cell RNA sequencing to make it possible to identify and characterize cellular sub-populations. Dr Greg Hundley:             The investigative team performed enzymatic dissociation of 4 whole mouse aortas, followed by single-cell sequencing of over 10,000 cells. Dr Carolyn Lam:                Wow. What did they find? Dr Greg Hundley:             Well using cluster analysis of gene expression from the aortic cells, they identified 10 populations of cells representing each of the main arterial cell types. There were fibroblasts, vascular smooth muscle cells, endothelial cells, immune cells, including monocytes, macrophages, and lymphocytes. And importantly, there were 3 distinct endothelial cell sub-populations with differences in them driven by major functional gene programs including adhesion and lipid handling.                                                 Comparison of aortic single-cell RNA sequence data sets from normal and Western diet-fed mice suggested that these sub-populations exist under both dietary conditions and have some unified responses to diet alteration. Also, immunofluorescence using single marker genes to identify endothelial cell sub-populations showed that the VCAM1 positive population was spatially located in regions of disturbed flow like the lesser curve of the aorta. Dr Carolyn Lam:                Okay. So bring it home for us, Greg. What does this mean clinically? Dr Greg Hundley:             Yeah exactly, Carolyn. So, characterizing functional sub-populations may serve as a novel method for understanding endothelial health in patients with vascular disease. And although aortic endothelial cell sub-populations demonstrate some unified responses to vascular disease relevant stimuli, like a Western diet, functionally different sub-populations may contribute differentially to vascular diseases, enabling sub-population targeted therapies to perhaps be implemented in the future. Dr Carolyn Lam:                Cool. So Greg, cardiomyopathies have often been seen as genetic in origin, but what about potentially modifiable causes? So, this next paper that I picked looked at that, and it's from corresponding author Dr Rosengren from Sahlgrenska University in Gothenburg, Sweden, who with her colleagues, sought to investigate a potential link between obesity in adolescence and being diagnosed with cardiomyopathy in adulthood.                                                 So, this was a nation-wide register-based prospective cohort study of almost 1 million 690,000 adolescent men who were enlisted for compulsory military service from 1969 to 2005. Now at baseline, body mass index, blood pressure, and medical disorders were registered, along with test results for fitness and muscle strength. Cardiomyopathy diagnosis was then identified from the National Hospital Register and Cause of Death Register.                                                 So, they found that during a median follow-up of 27 years, 4,477 cases of cardiomyopathy were identified, of which 59% were dilated, 15% were hypertrophic, and 11% were alcohol or drug-induced. Increasing body mass index, or BMI, was strongly associated with elevated risk of cardiomyopathy, especially dilated cardiomyopathy, starting at levels considered normal, meaning a BMI of 22.5 to less than 25 kilograms per squared meters.                                                 And this was even after adjusting for age, years, center, and baseline comorbidities. There was a more than 8 fold increased risk of cardiomyopathy at a body mass index of 35 and above, compared with a BMI of between 18.5 and less than 20. Dr Greg Hundley:             So, it sounds like BMI elevations and cardiomyopathies don't go together. So, what are the clinical implications? Dr Carolyn Lam:                This really shows that even mildly elevated body weight in late adolescence may contribute to being diagnosed with cardiomyopathy in adulthood. So, the already marked importance of weight control in youth is really further strengthened by these findings, as well as the greater evidence for obesity as a potential important cause of adverse cardiac remodeling that is independent of clinically evident ischemic heart disease. Dr Greg Hundley:             Outstanding. So, BMI, not good. Dr Carolyn Lam:                Nope, Greg. High BMI, not good. That was fun, Greg. So, shall we move on to our feature discussion? Dr Greg Hundley:             Absolutely. Dr Carolyn Lam:                For our feature discussion today, we are talking about a familiar problem, but just so very important, and that is hypertension. And guess what? Our feature paper discusses a new first in class centrally-acting renin-angiotensin system blocker that has such remarkable initial results. I am so pleased to have with us the corresponding author for the paper, Dr Keith Ferdinand from Tulane University School of Medicine, as well as our Guest Editor, Dr David Calhoun from University of Alabama and Birmingham.                                                 Keith, could you start by telling us a little bit about the kinds of patients you see there in New Orleans that struggles with hypertension control perhaps? And then, please tell us about Firibastat. Dr Keith Ferdinand:         I'm in New Orleans. In fact, I'm a native New Orleans. And as you know, most of the south and southeast and part of the United States has a high proportion of African American or US blacks. This population has higher rates of hypertension, increased prevalence, more severe hypertension, and more uncontrolled hypertension.                                                 We also note in the south that there tends to be an increase in obesity, which is a powerful risk factor for all patients with hypertension, regardless of race or ethnicity. And unfortunately, the rates of obesity appear to be increasing. So based on the fact that we have an increase in obesity, we have many patients whose blood pressures are not controlled, and some of the previous data have suggested less response to first step or monotherapy with ACE inhibitors and angiotensin receptor blockers, I initiated a trial with a first in its kind oral active brain aminopeptidase A inhibitor. Dr Carolyn Lam:                Wow. Could you tell us a little bit more about brain aminopeptidase, and this new drug Firibastat? Dr Keith Ferdinand:         Most people don't know anything about this molecule, because this is something that was discovered by some French physiologists. They approached me to design the clinical trial here in the United States. And what it does is, it blocks the conversion of angiotensin II to angiotensin III in the brain. Angiotensin III is actually the active component of the renin-angiotensin system centrally, and if you block angiotensin III production, it has a triple therapy effect.                                                 One is that it causes the diuresis. It decreases sympathetic tone, and it stimulates the carotid artery, such that you have, again, a decrease in sympathetic tone. Now, why choose it for patients who are obese, and why want to include a large proportion of non-Hispanic blacks here in the United States? Well, the reasons are that when you look at some of the bench research using rats, it appears to have a more beneficial effect in DOCA-salt rats, which is a model for salt-resistant hypertension.                                                 Salt-resistant hypertension is more common in blacks, more common in patients with obesity, and may indeed be one of the reasons why monotherapy or first-step with conventional renin-angiotensin system agents, specifically ACE inhibitors and ARBs, have not been as effective in the past. Dr Carolyn Lam:                Gosh. That is so interesting, and it's really making me think about my patients too here in Asia, where we have a lot of salt-sensitive hypertension. Now, could you please tell us about the trial you did, and what you found? Dr Keith Ferdinand:         We looked at a cohort of patients. All of the patients were overweight and obese. They were washed out for 2 weeks, and had a systolic blood pressure of 145-170, and a diastolic of less than 105. We wanted to get at least 50% self-identified blacks or Hispanics, and I suspect that any patient who meets this phenotype, and that would include Asians, or even Whites, may respond similarly.                                                 We then placed them in an open label format, and I can discuss why we used an open label, with monotherapy with Firibastat. After 2 weeks, we then titrated the dose level from 250 twice daily to 500 twice daily if needed, and we had a low dose thiazide and hydrochlorothiazide 25 mg addition, if needed, for escape, if patients had a blood pressure greater than 160/100.                                                 The other thing that was interesting and unique about this particular trial is that we used the automatic office blood pressure, where the blood pressure was taken 6 times. The first time was discarded, and then averaged, without a particular doctor or a nurse being there to do the blood pressure. We felt that this was a valid means of getting blood pressure loaded. It tends to mimic, to a large extent, what you see in 24 hour inventory daytime systolic blood pressure.                                                 So, this was a valid means of measuring blood pressure loads. This was a relatively high risk patients. And these were patients whom, previously, probably would not have responded as well to monotherapy with ACE inhibitors or ARBs. Dr Carolyn Lam:                That's really clear, and clever design. I would love to hear a little bit more about why the open label, and of course, the results. Dr Keith Ferdinand:         Well, that's one of the criticisms of this study, but actually, we presented to the FDA when we were discussing designing this trial, perhaps doing a placebo control trial. And we were told by the FDA that if you use a valid means of measuring blood pressure load, so that would be ambulatory blood pressure, or automated office blood pressure, that a placebo would not be necessary, because those means of checking blood pressure load would be considered a true valid means of finding a blood pressure effect.                                                 The other thing is, dealing with minority patients, and really dealing with patients in general, for blood pressure, if they have substantial hypertension, the message has been out there that this is a killer and cause of cardiovascular disease. It would probably have been very difficult to enroll the patients, you've got 254 patients in a national study. It would have been very difficult to enroll these patients, who would have known easily that they had substantial elevation of blood pressure, and we said, "You know, 50% chance you're going to get a sugar pill that has no effect." Dr Carolyn Lam:                Right. Right. Very nice. The results? Dr Keith Ferdinand:         Well, the results were a robust 9.7 mm reduction in systolic blood pressure. At day 56, the p-value was less than 0.0001. And when you do a sub-group analysis of patients who were in the study, it was effective for persons who are under 65, or over 65, male or female. All patients were overweight, and the patients who were obese, with a BMI of 30 or above, had a trend towards even a better blood pressure effect, which again, is not seen with first step with conventional ACE and ARBs.                                                 We also did an analysis based on black and non-black, and there was no difference, again with the trend towards the black patients actually doing fairly well. So, the take home from the particular study was this is the first in its kind, new approach to central Ras blockage with aminopeptidase A inhibitor, that was effective in a population which was overweight and obese, with over 50% minority, and showed substantial blood pressure reduction using a valid means of checking blood pressure, the automated blood pressure in the clinic. Dr Carolyn Lam                  Keith, congratulations. A very important study. David, could I bring you in here? What were your thoughts as you were managing this paper, and what do you think are the future steps here? Dr David Calhoun:            Looking at the submission, I was obviously excited about the results and the potential implications. I think, like Keith, in treating a lot of resistant or obesity-related hypertension, we're frustrated that control rates are not better, that the initial response to monotherapy is not better, and that's particularly true of Ras blockers. I think many of us are investigating the initial use of Ras blockers for a variety of reasons related to outcome benefit and reduction in incident and diabetes.                                                 So, I know I like to start with such an agent. I'm particularly excited that there may be, firstly, a new opportunity to block the Ras system, and potentially comparable or even better in the most difficult patients to treat. That is, the African American and the Hispanic patients, who often have very severe hypertension. So, my initial reading was I was very excited to see the potential, and that was brought out by the reviews as well. They shared my excitement. So, I'm looking forward to Keith advancing this compound. Dr Carolyn Lam:                Indeed. Keith, I'm sure everyone's thinking now, wow, remarkable results. What's the drawbacks? How well-tolerated was this drug? Dr Keith Ferdinand:         One of the drawbacks is that the structure of Firibastat included a sulfhydryl group. And we saw with early studies with captopril, which also has a sulfhydryl group, some skin rash, and we saw those similar changes with some of the patients in this particular study. At least 2 of them were suggested to potentially have erythema multiforme, although this was not proven. This was an investigator initiated adverse event.                                                 So, I don't know if we're going to be able to structure a similar type of aminopeptidase inhibitor without a sulfhydryl group. The other thing is that in its presence formulation, it's given twice daily. We know optimally you'd like to have a long-acting agent that can be given once daily. And I don't think we need a placebo control trial, but we may need to do a trial where patients are on 2 or more medications, and then, you add the Firibastat versus adding placebo. But, I don't think at this particular point, we need to get some of these more difficult to treat patients, and just place them on placebo, and watch and see what happens.                                                 We know what happens. The blood pressure goes up. Many of them may have acute heart failure, or progression of renal failure. And I just don't think it's necessary. And the FDA doesn't think it's necessary to prove that hypothesis. Dr Carolyn Lam:                David, what do you think about that? Do we need a placebo control trial? And that use of ambulatory blood pressure, that's novel aspects of this trial too. Dr David Calhoun:            I think use of placebo comparison has been for the traditional or conventional approach. I think most investigators, most clinicians, sort of anticipate seeing the placebo corrected effect. So, I think the results would have been, or will be potentially, more compelling if that's done. But, I can also appreciate Keith's contention, and it sounds like the FDA, that in this day and age, with use of automated office blood pressure measurements tend to minimize that white coat effect, and particularly true of ambulatory monitoring, that it may be that not using a placebo comparison maybe is compelling as well. Dr Carolyn Lam:                Indeed. I really enjoy actually just digging deep into the study like this. Keith, if I could just ask for some final words from you, learning lessons, or even what have you got planned next. Dr Keith Ferdinand:         The first lesson is, we need to continue to pay attention to hypertension. It's kind of been placed on the back burner with more interest now in diabetes and sugar, a lot of interest in lipids because of some of the new agents. But if you look across the globe, Asians, blacks, whites, regardless of race or ethnicity or geography, hypertension is the most potent cardiovascular risk factor, and I think we need to continue to address that.                                                 In terms of this particular agent, I believe that we will have to have some sort of placebo arm, but again, I think it's going to be built on a conventional medication, and then randomized with Firibastat versus placebo on top of conventional medications. In a more severe or a more difficult to treat hypertension, I'm just not really convinced that we need to do a purely placebo arm. Dr Carolyn Lam:                Great, Keith. And David, how about yourself? Any take home messages? Dr David Calhoun:            I think when there's a new in-class compound, I think that's always exciting, particularly when it has the initial results, preliminary results, that Keith is reporting. As many agents as there are out there to treat hypertension, we still are not doing as well as we should be. I think it can only help to have additional classes of agents as therapeutic options, and I think that's particularly true with minority patients, who are, as Keith has indicated, are at the biggest need in terms of controlling blood pressure. Keith, these initial results are very exciting, and I look forward to future studies. Dr Carolyn Lam:                Completely sharing your enthusiasm here. Thank you so much, Keith, for publishing this remarkable paper with us at Circulation. Thank you, David, for helping us manage it.                                                 And thank you, audience, for joining us today. You've been listening to Circulation on the Run. Don't forget to tune in again next week.                                                 This program is copyright American Heart Association 2019.  

This election was shaped by two men with very different characters. One of them was defined by certainty and the other by his insecurities. Erik Jensen on how leadership interacts with uncertainty, and what it means for the country.Guest: Editor-in-chief of Schwartz Media and author of Quarterly Essay 74: The Prosperity Gospel Erik Jensen.Background reading:Quarterly Essay: The Prosperity GospelThe Saturday PaperThe MonthlyFor more information on today’s episode, visit 7ampodcast.com.au. See acast.com/privacy for privacy and opt-out information.

Episode Three & our first with a Guest Editor. Thom Baker selects Uncut Magazine's Rebel Rebel - A Tribute To David Bowie from April 2008.

Episode Three & our first with a Guest Editor. Thom Baker selects Uncut Magazine's Rebel Rebel - A Tribute To David Bowie from April 2008.

In the grimdark future, there is only Guest Editor. Digi Hosts: Shin Garrett and Swat Kat Digi Notes: The Black Gate Resident Evil 2 Beat Kidz Yu-Gi-Oh cards bootlegged by their own US distributor Peter Thiel is a vampire the Battle Network anime and wearing AIs like armor Komm Süsser Tod Gauntlet: Seven Sorrows actually happened "I don't believe you, Pete." Lego ripping off Battle Network Violet wands

Our guest is Professor Wayne Derman of Stellenbosch University, South Africa. Professor Derman is the Guest Editor of the special September 2018 issue of CJSM devoted to the management of pain in athletes.

Vallerie McLaughlin, MD from Michigan Medicine's Cardiovascular Center explains the basics of clinical trials in part 2 of her discussion. Dr. McLaughlin is the Director of the Pulmonary Hypertension Program at the University of Michigan in Ann Arbor. She is a Fellow of the American College of Cardiology, American College of Chest Physicians, and American Heart Association (AHA). Dr. McLaughlin has been the Principal Investigator of several major clinical trials of drug therapies for pulmonary arterial hypertension and has published numerous papers in this field. Dr. McLaughlin is an editorial board member of Chest, a Guest Editor for the Journal of the American College of Cardiology, and past Editor-in-Chief of Advances in Pulmonary Hypertension.  Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @antidote_me @accpchest @umichCVC

Vallerie McLaughlin, MD from Michigan Medicine's Cardiovascular Center breaks down the different phases of clinical trials in part 1 of her discussion. Dr. McLaughlin is the Director of the Pulmonary Hypertension Program at the University of Michigan in Ann Arbor. She is a Fellow of the American College of Cardiology, American College of Chest Physicians, and American Heart Association (AHA). Dr. McLaughlin has been the Principal Investigator of several major clinical trials of drug therapies for pulmonary arterial hypertension and has published numerous papers in this field. Dr. McLaughlin is an editorial board member of Chest, a Guest Editor for the Journal of the American College of Cardiology, and past Editor-in-Chief of Advances in Pulmonary Hypertension.  Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @umichCVC @antidote_me @accpchest 

In this eight episode of the bodymindself™ podcast psychologist and cognitive scientist John Francis Leader (JFL) meets Professor of Creative Technologies Aljosa Smolic to discuss the relationship between technology and creativity. Professor Aljosa Smolic is the Professor of Creative Technologies at Trinity College Dublin. Before joining Trinity, Prof. Smolic was with Disney Research Zurich as Senior Research Scientist and Head of the Advanced Video Technology group, and with the Fraunhofer Heinrich-Hertz- Institut (HHI), Berlin, also heading a research group as Scientific Project Manager. At Disney Research he led over 50 industrial R&D projects that have resulted in technology transfers to a range of Disney business units. They include film studios, TV broadcasters, consumer products and are used in professional production today. Prof Smolic is Associate Editor of the IEEE Transactions on Image Processing and served as Guest Editor for the Proceedings of the IEEE, IEEE Transactions on CSVT, IEEE Signal Processing Magazine, and other scientific journals. He is a Committee Member of several conferences, and served in several Chair positions of conferences. The core objective of his research at TCD V-SENSE is to extend the dimensions of visual sensation through novel algorithms and workflows for image-based visual computing expanding the classical 2D video viewing experience common today, and to enable and support new consumer behaviours and preferences in consumption and creation of such content. The bodymindself™ podcast is an ongoing series of conversations between JFL and others on the topics of applied psychology and cognitive science, experiential learning, perception, virtual and mixed reality, embodiment, mental processes and identification. The aim of the series is to include the voices of people from very diverse backgrounds, ranging from academia to those working on the frontline in applied fields, with the hope of gaining an even greater systematic understanding of the topics being explored. All references and views expressed are those of the person who expressed them and not necessarily those of JFL. Your comments, shares, likes and dislikes are very welcome and will help guide future discussions. To stay up to date follow on twitter.com/jfldotcom, subscribe on @jfldotcom or itun.es/i67P795 and visit jfl.com . References Full references, the video version of the episode and other information can be found at: http://jfl.com/x/technology-creativity-professor-aljosa-smolic-jfl-bodymindself Special thanks to Dr Abraham Campbell at University College Dublin for coordinating this episode.

Ep.3: Passionate About Project-Based Learning Moderator: Jane C. Lo is Assistant Professor of Social Science Education in the School of Teacher Education at Florida State University. She studies social studies education broadly, with a specific focus on civic education. Her recent works on student political engagement and project-based learning can be found in Theory and Research in Social Education as well as Democracy & Education. Reach Jane at jlo@fsu.edu. This podcast is an audio extra to her January/February 2018 articles in Social Education, where she served as Guest Editor. Social Education is a journal of the National Council for the Social Studies. Link to Jane’s Social Education article here: https://www.socialstudies.org/node/50761 Heard in the Podcast: John Larmer is editor in chief at the Buck Institute for Education (BIE), where he wrote and edited BIE’s project-based curriculum units for high school government and economics, and the PBL Toolkit Series. In 2015, he co-authored Setting the Standard for Project Based Learning, published by ASCD. For 10 years John taught high school social studies and English and co-founded a restructured small high school. He can be reached at johnlarmer@bie.org or on Twitter @johnlbie. Stacie Brensilver Berman taught U.S. History for 10 years at Edward R. Murrow High School in Brooklyn, N.Y. She is currently a doctoral candidate in Social Studies Education at New York University writing her dissertation, “Behind the Times: The Struggle to Include LGBTQ History in High School U.S. History Classes.”  Robert Hallock teaches social studies at Sammamish High School in Bellevue, Washington, and has served as a reader for the AP World History Exam. He can be reached at hallockr@bsd405.org.  ____ Social Education co-authors: “The ‘Secret Ingredients’ of Problem-Based Learning: A World History Perspective” (page 40) Robert Hallock (credited above) Kathryn Smoot currently teaches social studies in Florham Park, N.J. She previously taught AP World History for five years at Sammamish High School in Bellevue, Washington.  ___ “Learning through Doing: A Project-Based Learning Approach to the American Civil Rights Movement” (page 35) Stacie Brensilver Berman (credited above) Diana B. Turk is co-author of  “Teaching Recent Global History” (Routledge, 2014) and Teaching U.S. History (Routledge, 2009), and author of several articles and chapters on innovative approaches to teaching history in middle and secondary schools. Become a member of NCSS here: https://www.socialstudies.org/membership/join_renew

Dr. Williams is Professor and Chair, Department of Health, Kinesiology, and Recreation at University of Utah. Dr. Williams has previously held senior leadership positions in the UK (Head of Life Sciences, Brunel University London) and Australia (Associate Dean for Research, Faculty of Health Sciences, University of Sydney).    His research interests focus on the neural and psychological mechanisms underpinning the acquisition and development of perceptual-cognitive and perceptual-motor skills. He has published almost 180 journal articles in peer-reviewed outlets in numerous fields including exercise and sports science (e.g., Medicine and Science in Sport and Exercise, Journal of Sport and Exercise Psychology, Sports Medicine), experimental psychology (e.g., Acta Psychologica, British Journal of Psychology, Experimental Psychology, Visual Cognition, Journal of Experimental Psychology), neuroscience (Neuroscience Letters, Human Brain Mapping, Neuroimage) and medicine (The Lancet, British Medical Journal, Medical Education). He has written 15 books, almost 80 book chapters, 60 professional articles, 91 journal abstracts, and has delivered almost 200 keynote and invited lectures in over 30 countries. He is Editor-in-Chief for the Journal of Sports Science and Executive Editor for the journal Human Movement Science. Also, he sits on the editorial boards of the Scandinavian Journal of Science and Medicine in Sport, Research Quarterly for Exercise and Sport, and Frontiers of Cognition, and Frontiers in Psychology (Performance Science). Moreover, he has acted as a Guest Editor of special issues for prestigious journals such as Journal of Sport Sciences, Journal of Motor Behavior, Journal of Sport and Exercise Psychology, and Journal of Experimental Psychology: Applied.   Subscribe to the Way of Champions Podcast on iTunes   Show Notes 5:45 He was one of first UK graduates in Sport and Exercise Science 8:20 Mark discusses the concepts of reinvestment and paralysis by analysis 17:15 The role of the coach in practices 25:45 Differences between specialization and early engagement 35:35 Coaching is an art form but there’s no reason it cannot be informed by science 48:20 Mark’s biggest coaching pet peeve   Get in Touch Email: mark.williams@health.utah.edu   Join Us at Way of Champions 2018   Take your Coaching to the Next Level with Transformational Coaching     If you are enjoying our podcast, please help us out and leave a review on iTunes. How to leave an iTunes rating or review for a podcast from your iPhone or iPad   Launch Apple’s Podcast app. Tap the Search tab. Enter the name Way of Champions. Tap the blue Search key at the bottom right. Tap the album art for the Way of Champions podcast. Tap the Reviews tab. Tap Write a Review at the bottom. Thanks so much, every review helps us to spread this message!

Themed issue Guest Editor, Dr Frank Tu, discusses his top papers from the Benign Gynaecology special issue of BJOG. This podcast is an abridged version of the original Editor's Choice, available http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14320/full.

In light of the upcoming Regenerative Medicine Special Focus Issue on immunological challenges and opportunities in regenerative medicine, RegMedNet conducted an interview with Professor Paul Fairchild, Guest Editor of the issue. This interview on immunology within the field of regenerative medicine provides a great insight into the interface between stem cell biology and immunology – to bring cell therapies into the clinic we must overcome challenges such as immunogenicity. The work carried out by researchers such as Professor Paul Fairchild, a member of the UK Regenerative Medicine Platform (RMP)'s Immunomodulation Hub, will have a huge impact on the field of regenerative medicine.

ACS Synthetic Biology August 2016 podcast interview with Harold Fellermann, Guest Editor, Special Issue on Programmable Biology.

EAQ Editor, Linda Skrla, interviews Guest Editor, Terry Orr, and UCEA head, Michelle Young, about leadership preparation in education.

1) The association between hospitalization and care after transient ischemic attack or minor stroke2) e-Pearl topic: Neuroretinitis3) Topic of the month: Migraine awareness seriesThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Moira Kapral about her paper on the association between hospitalization and care after transient ischemic attack or minor stroke. Dr. Sarah Wesley is reading our e-Pearl of the week about neuroretinitis. Dr. Tesha Monteith interviews Dr. Stephen Silberstein about the topic of migraine clinical trials: A drug therapy and neuromodulation update. DISCLOSURES: Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke viamobile telemedicine;” and gave legal expert review.Dr. Kapral serves as Guest Editor for Cardiovascular Quality and Outcomes; serves as an editorial board member of Circulation; receives research support from the Heart and Stroke Foundation of Canada.Dr. Wesley serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Monteith serves as an editorial advisory board member for Neurology Now and receives research support from the NIH.Dr. Silberstein serves as an editorial board member of Cephalalgia, Current Pain and Headache Reports, CNS Drugs, Topics in Pain Management and Neurology®; serves on the scientific advisory board for Alder, Allergan, Inc., Amgen, Avanir, eNeura, ElectroCore Medical, Medscape, Medtronic, Inc., Mitsubishi Tanabe Pharma Corporation, Neuralieve, NINDS, Pfizer Inc, Supernus and Teva Pharmaceutical Industries Ltd.; is a consultant for Allergan, Inc., Amgen, eNeura, ElectroCore Medical, Mitsubishi Tanabe, Medtronic, Inc., Neuralieve, Pfizer, Inc, Supernus and Teva Pharmaceutical Industries Ltd.; receives research support from American Headache Society®, International Headache Society and the NIH.

In this podcast for HMF's November 2015 issue, Guest Editor for the issue, Hy Eliasoph, MA, speaks with Janice K. Popp, MSW, RSW, and Ann Casebeer, MPA, PhD, about their paper, "Be careful what you ask for: Things policy-makers should know before mandating networks."   To view the article, click here.

1) Utilization of antiepileptic drugs in pregnant women in Florida Medicaid and 2) Topic of the month: Stroke in systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Nathan Fountain interviews Dr. Xuerong Wen about her paper on the utilization of antiepileptic drugs in pregnant women in Florida Medicaid. Dr. James Addington is reading our e-Pearl of the week about primary orthostatic tremor. In the next part of the podcast Dr. Michelle Johansen interviews Dr. Victor Urrutia about the topic of hemoglobinopathies and stroke. The participants had nothing to disclose except Drs. Fountain, Addington, Johansen and Urrutia.Dr. Fountain performs clinical procedures as epileptologist (100% effort) at the University of Virginia Comprehensive Epilepsy Program; receives research support from UCB, SK Life Sciences, Inc., Sunovion Pharmaceuticals, Inc., Medtronic, Inc., NeuroPace, Inc. and the NIH.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Johansen serves as a scientific advisory member of Stroke and as a contributor to Blogging Stroke.Dr. Urrutia serves as a Guest Editor for Frontiers; was asked to consult for New York University to conduct a stroke center certification mock survey; receives research support from Genentech, Inc. and the NIH.

1) Current practices in feeding tube placement for US acute ischemic stroke inpatients and 2) Topic of the month: Management of sports concussion. This podcast for the Neurology Journal begins and closes with Dr. Ted Burns, Section Editor Podcasts, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Kevin Barrett interviews Drs. Ben George and Adam Kelly about their paper on current practices in feeding tube placement for US acute ischemic stroke inpatients. Dr. James Addington is reading our e-Pearl of the week about childhood stroke: think metabolic. In the next part of the podcast Dr. Stephen Donahue interviews Dr. Michael Jaffee about the definition of concussion and how the grading has evolved over recent years. The participants had nothing to disclose except Drs. Barrett, George, Kelly, Addington and Jaffee.Dr. Barrett serves as an editorial board member of Neurology; serves as an Associate Editor of Neurohospitalist and receives research support from the NIH.Dr. George receives research support from the American Heart Association/American Stroke Association and the Parkinson's disease Foundation.Dr. Kelly serves as an editorial board member of Continuum; serves as Guest Editor for Cerebrovascular Disease issue, April 2014 and received research support from the Donald W. Reynolds Foundation.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Jaffee serves on the scientific advisory boards for WETA (Public Television) Brainline, U. S. Army Peer Review Alzheimer Research Program and the NIH translational research outcome consortium review.

It's the LAST GASP of Guest Editor's Month! Join Paul "The Producer" Spataro, Dr. Bill Robinson, Dave Atteberry and Chris "Hair Metal Hero" Tyler as they go out with a FULL-BLOWN ARNIE-THON!! In STARK CONTRAST to the unscripted, unresearched commentaries of Gardner and Honeywell, this commentary is a structured, acedemic analysis of this oscar winning masterpiece. Honest. Not a SINGLE Arnie impression. Nope. Not ONE. Heads are gonna roll when the bosses get back!Feedback for this show can be sent to: commentary@twotruefreaks.comTwo True Freaks! is a proud member of BOTH the Comics Podcast Network (http://www.comicspodcasts.com/) and the League of Comic Book Podcasts (http://www.comicbooknoise.com/league/)!! Follow the fun on Facebook at https://www.facebook.com/groups/113051642052970/ THANK YOU for listening to Two True Freaks!!

Listen to highlights from ACS Synthetic Biology's June 2014 Special issue on Cell-Free Synthetic Biology. Managing Editor, Ranjini Prithviraj, speaks with Guest Editor, Dr. Michael Jewett, and with Sukanya Iyer, a first author on one of the papers featured in this issue.

Listen to highlights from the April 2014 issue of ACS Synthetic Biology. Managing Editor, Ranjini Prithviraj, speaks with Cynthia Collins, Guest Editor of this month's special issue on Cell-Cell Communication.

Managing Editor, Ranjini Prithviraj, speaks with Dr. Tom Ellis - a Guest Editor of this month's Special Issue based on research presented at SB6.0: The Sixth International Meeting on Synthetic Biology.

Patrick McGuinness, poet, novelist and Guest Editor of Poetry Review, talks to Sam Willetts, contributor to the summer 2013 issue, 'Poetry &'. Recorded at St Anne's College, Oxford, June 2013. Produced by Michael Sims and Michael Umney.

A fascinating conversation between Bernardine Evaristo, Guest Editor of Poetry Review, and contributing poets Edward Doegar, Sophie Mayer, Richard Scott and Warsan Shire, about 'Offending Frequencies', the winter 2012 issue of Poetry Review. Recorded at Keats House, London, on 24 January 2013. Produced by Michael Sims and Michael Umney. Music: 'Tara' by Salam (http://www.wmrecordings.com/releases/wm016.htm)

Hew Strachan, Chichele Professor of the History of War at the University of Oxford and Co-Editor of War in History, and Edward Madigan, Resident Historian at the Commonwealth War Graves Commission and Guest Editor of volume 20, issue 1 of War in History, discuss the themes of courage and cowardice throughout history. This issue marks the beginning of War in History’s 20th year. Posted January 2013.

ACS Synthetic Biology Managing Editor Ranjini Prithviraj speaks with Guest Editor, Douglas Densmore of Boston University along with Erik Winfree, Pakpoom Subsoontorn and Jongmin Kim of Caltech, all authors of manuscripts featured in this issue.

Guest Editor, Joanne Ciulla, interviews Osam Edim Temple on the challenges, metaphysical and otherwise, of leadership in Africa.

Dr. David Barton, Guest Editor of the special series Bayesian Networks in Environmental and Resource Management discusses the basics of Bayesian approaches in environmental management.

If you experience any technical difficulties with this video or would like to make an accessibility-related request, please send a message to digicomm@uchicago.edu. Poet, essayist, and translator, Lyn Hejinian is the author or co-author of fourteen books of poetry, including The Beginner (Spectacular Books, 2000), Happily (Post Apollo Press, 2000), Sight (with Leslie Scalapino, 1999), The Cold of Poetry (1994), The Cell (1992), My Life (1980), Writing Is an Aid to Memory (1978), and A Thought Is the Bride of What Thinking (1976). Description and Xenia, two volumes of her translations from the work of the contemporary Russian poet Arkadii Dragomoshchenko, have been published by Sun and Moon Press. In 2000, the University of California Press published a collection of her essays entitled The Language of Inquiry, and she was Guest Editor of The Best American Poetry 2004. From 1976 to 1984, Hejinian was editor of Tuumba Press, and since 1981 she has been the co-editor of Poetics Journal. She is also the co-director of Atelos, a literary project commissioning and publishing cross-genre work by poets. Other collaborative projects include a work entitled The Eye of Enduring undertaken with the painter Diane Andrews Hall and exhibited in 1996, a composition entitled “” with music by John Zorn and text by Hejinian, a mixed media book entitled The Traveler and the Hill and the Hill created with the painter Emilie Clark (Granary Press, 1998), and the experimental film Letters Not About Love, directed by Jacki Ochs, for which Hejinian and Arkadii Dragomoshchenko wrote the script. Her honors include a Writing Fellowship from the California Arts Council, a grant from the Poetry Fund, a Translation Fellowship from the National Endowment of the Arts, and a Fellowship from The Academy of American Poets. She lives in Berkeley and teaches at the University of California.

In order to further explain topics of interest to a diverse audience, the Journal of the American Chemical Society introduces podcast interviews. The second topic is an interview with JACS Associate Editor Jeffrey S. Moore, who serves as Guest Editor of the second JACS Select Issue and discusses the Molecular Design of Thin Film Optoelectronic Materials for Solar Cells.

In order to further explain topics of interest to a diverse audience, the Journal of the American Chemical Society introduces podcast interviews. The first topic is an interview with JACS Associate Editor William R. Roush, who serves as Guest Editor of the first JACS Virtual Issue and discusses the Total Synthesis of Biologically Active Natural Products.

Software Process and Measurement Show 20! Show 20 features Part 2 of an interview with Dave Garmus discussing IFPUG Function Points.  David Garmus is one of the Founders of The David Consulting Group (DCG). David is an acknowledged authority in the sizing, measurement and estimation of software application development. He is a Past President of the International Function Point Users Group (IFPUG) and a member of their Counting Practices Committee. Mr. Garmus is also a member of PMI, SEI and QAI. He has a BS from UCLA and an MBA from Harvard University Graduate School of Business Administration. He has spoken at numerous conferences and has written many articles and several books, including: ·        Measuring The Software Process: A Practical Guide To Functional Measurements, Prentice Hall, 1996 ·        Function Point Analysis; Measurement Practices for Successful Software Projects, Addison-Wesley, 2001 ·        IT Measurement; Practical Advice from the Experts, Addison-Wesley, 2002 as a Contributor ·        “IT Metrics and Benchmarking," Cutter IT Journal, June & November 2003 issues, Guest Editor ·        “Identifying Your Organization’s Best Practices," CrossTalk, June 2005 ·        “An Introduction to Function Point Counting," Projects & Profits, ICFAI, June 2005 ·        “The Principles of Sizing and Estimating Projects Using IFPUG Function Points," Software Tech News, June 2006                                                       The essay is titled “Tailoring and Worktypes."  The text of this commentary can be found at www.tcagley.wordpress.com.  Comments and corrections are welcome.   Remember that comments and feedback are welcome!  There are a number of ways to share your thoughts . . .  Email SPaMCAST at spamcastinfo@gmail.com Voice messages can be left at 1-206-888-6111 Twitter – www.twitter.com/tcagley BLOG – www.tcagley.wordpress.com Future Events: On Tuesday November 13th I am presenting Traceability: A Proposal for a Scalable Approach, Agile To Formal at the Fourth Annual International Conference on Software Process Improvement in Orlando.    Information can be found at www.icspi.com.  On November 16th I will be delivering a tutorial titled “Implementing an Effective Measurement Program."  Spamcast listeners should let me know if you are coming and we can schedule a meet up.   Next Software Process and Measurement Cast: The next Software Process and Measurement Cast will feature an interview with Miranda Mason of Accenture on sourcing metrics programs.   Sourcing your metrics program is not a topic that gets a lot of press however the practice is becoming more common and bears examination.   

Software Process and Measurement Cast Show 19! Show 19 features an interview with Dave Garmus discussing IFPUG Function Points.  David Garmus is one of the Founders of The David Consulting Group (DCG). David is an acknowledged authority in the sizing, measurement and estimation of software application development. He is a Past President of the International Function Point Users Group (IFPUG) and a member of their Counting Practices Committee. Mr. Garmus is also a member of PMI, SEI and QAI. He has a BS from UCLA and an MBA from Harvard University Graduate School of Business Administration. He has spoken at numerous conferences and has written many articles and several books, including: ·        Measuring The Software Process: A Practical Guide To Functional Measurements, Prentice Hall, 1996 ·        Function Point Analysis; Measurement Practices for Successful Software Projects, Addison-Wesley, 2001 ·        IT Measurement; Practical Advice from the Experts, Addison-Wesley, 2002 as a Contributor ·        “IT Metrics and Benchmarking," Cutter IT Journal, June & November 2003 issues, Guest Editor ·        “Identifying Your Organization’s Best Practices," CrossTalk, June 2005 ·        “An Introduction to Function Point Counting," Projects & Profits, ICFAI, June 2005 ·        “The Principles of Sizing and Estimating Projects Using IFPUG Function Points," Software Tech News, June 2006 The essay is titled “Stockholm Syndrome and Outsourcing."  The text of this commentary can be found at www.tcagley.wordpress.com.  Comments and corrections are welcome. Remember that comments and feedback are welcome!  There are a number of ways to share your thoughts . . .  Email SPaMCAST  at spamcastinfo@gmail.com Voice messages can be left at 1-206-888-6111 Twitter – www.twitter.com/tcagley BLOG – www.tcagley.wordpress.com Future Events: On October 11 I will be presenting a DCG / CAI Webinar titled Benchmarking Performance for the Bottom Line - October 11th, 2007, 11:00 am - 12:30 pm EST go to www.davidconsultingroup.com website to register.   On Tuesday November 13th I am presenting Traceability: A Proposal for a Scalable Approach, Agile To Formal at the Fourth Annual International Conference on Software Process Improvement in Orlando.    Information can be found at www.icspi.com.  On November 16th I will be delivering a tutorial titled “Implementing an Effective Measurement Program."  Spamcast listeners should let me know if you are coming and we can schedule a meet up.  Next Software Process and Measurement Cast: The next Software Process and Measurement Cast will feature Part 1 of the interview with Dave Garmus covering IFPUG Function Points, if you are interested in functional measurement this is a must cast.